StockScouter

The StockScouter® System is a proprietary stock scoring model which covers U.S. companies listed on the major exchanges. The 10 (best) to 1 (worst) score is derived from Fundamental, Technical, Ownership, and Valuation sub-models in combination with a Risk model which assesses the expected risk and return.

StockScouter Screening Tool StockScouter Top 50

PHIO PHIO PHARMACEUTICALS CORPORATION StockScouter® Report

7

StockScouter® Score

PHIO PHARMACEUTICALS CORPORATION, a micro cap company in the healthcare sector, is expected to outperform the market over the next six months with average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The enterprise value-to-sales ratio is much lower than the average for comparably-sized companies in the StockScouter universe. Very Positive
  • Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive

 

Concerns

  • The 50-day moving average for PHIO is significantly below its 200-day moving average. Negative
  • Short-term relative price momentum exhibits meaningful weakness. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be out of favor, stocks will be , and healthcare stocks will be out of favor.

Expected Risk/Return

Progress: 60% done.
Progress: 100% done.
Low
High

Core Model Grades

B
N/A
A
D

Previous Ratings

4
3
4